LTBP-3 promotes early metastatic events during cancer cell dissemination

[1]  W. Kiosses,et al.  Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma. , 2017, Cell reports.

[2]  Li Peng,et al.  Knockdown of Latent Transforming Growth Factor-β (TGF-β)-Binding Protein 2 (LTBP2) Inhibits Invasion and Tumorigenesis in Thyroid Carcinoma Cells , 2017, Oncology research.

[3]  Rosnah Binti Zain,et al.  Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance , 2017, PloS one.

[4]  R. Weinberg,et al.  Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas. , 2017, Cancer research.

[5]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[6]  Jun Yu,et al.  Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice , 2017, Oncogene.

[7]  Eduard Batlle,et al.  Understanding the molecular mechanisms driving metastasis , 2017, Molecular oncology.

[8]  J. Quigley,et al.  EGFR Regulates the Development and Microarchitecture of Intratumoral Angiogenic Vasculature Capable of Sustaining Cancer Cell Intravasation , 2015, Neoplasia.

[9]  J. Quigley,et al.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[10]  Jérôme Cros,et al.  Targeting the TGFβ pathway for cancer therapy. , 2015, Pharmacology & therapeutics.

[11]  D. Rifkin,et al.  Function of Latent TGFβ Binding Protein 4 and Fibulin 5 in Elastogenesis and Lung Development , 2015, Journal of cellular physiology.

[12]  R. Derynck,et al.  Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. , 2014, Current opinion in cell biology.

[13]  K. Kameyama,et al.  Latent TGF-β binding protein-2 is essential for the development of ciliary zonule microfibrils. , 2014, Human molecular genetics.

[14]  A. Moustakas,et al.  TGFβ and matrix-regulated epithelial to mesenchymal transition. , 2014, Biochimica et biophysica acta.

[15]  Michelle S. Miller,et al.  The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen–Goldberg syndrome , 2014, European Journal of Human Genetics.

[16]  S. Carr,et al.  Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters , 2014, eLife.

[17]  Boris Pasche,et al.  TGF-β: duality of function between tumor prevention and carcinogenesis. , 2014, Journal of the National Cancer Institute.

[18]  J. Quigley,et al.  Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. , 2013, Blood.

[19]  I. Rimann,et al.  Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination. , 2013, Cancer research.

[20]  L. Wakefield,et al.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.

[21]  J. Lebrun.  The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis , 2012, ISRN molecular biology.

[22]  R. Akhurst,et al.  Complexities of TGF-β Targeted Cancer Therapy , 2012, International journal of biological sciences.

[23]  E. Fishman,et al.  Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm , 2012, Nature Genetics.

[24]  Y. Nishimura,et al.  Selective inhibition of nuclear factor‐κB by nuclear factor‐κB essential modulator‐binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma , 2012, Cancer science.

[25]  Napoleone Ferrara,et al.  Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.

[26]  T. Walz,et al.  Latent TGF-β structure and activation , 2011, Nature.

[27]  P. Cowin,et al.  Choreographing Metastasis to the Tune of LTBP , 2011, Journal of Mammary Gland Biology and Neoplasia.

[28]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[29]  Y. Soini,et al.  Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma. , 2011, Human pathology.

[30]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[31]  Erin M. Conn,et al.  Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion. , 2009, The American journal of pathology.

[32]  P. E. Van den Steen,et al.  Neutrophil MMP-9 Proenzyme, Unencumbered by TIMP-1, Undergoes Efficient Activation in Vivo and Catalytically Induces Angiogenesis via a Basic Fibroblast Growth Factor (FGF-2)/FGFR-2 Pathway* , 2009, The Journal of Biological Chemistry.

[33]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[34]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[35]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[36]  J. Melamed,et al.  Perturbation of transforming growth factor (TGF)-ß1 association with latent TGF-β binding protein yields inflammation and tumors , 2008, Proceedings of the National Academy of Sciences.

[37]  James P. Quigley,et al.  Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis , 2008, Histochemistry and Cell Biology.

[38]  R. Weinberg,et al.  Mechanisms of malignant progression. , 2008, Carcinogenesis.

[39]  J. Quigley,et al.  Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis , 2007, Proceedings of the National Academy of Sciences.

[40]  J. Quigley,et al.  Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.

[41]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[42]  Andries Zijlstra,et al.  Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination. , 2005, Cancer research.

[43]  D. Rifkin,et al.  Fibronectin is required for integrin o:vβ6‐mediated activation of latent TGF‐β complexes containing LTBP‐1 , 2005 .

[44]  B. Park,et al.  Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter , 2005 .

[45]  P. Handford,et al.  Solution structure of the third TB domain from LTBP1 provides insight into assembly of the large latent complex that sequesters latent TGF-beta. , 2003, Journal of molecular biology.

[46]  Jackelyn A. Alva,et al.  Selective Binding of Lectins to Embryonic Chicken Vasculature , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  N. Yoshikawa,et al.  The 50-kDa protein of Apple chlorotic leaf spot virus interferes with intracellular and intercellular targeting and tubule-inducing activity of the 39-kDa protein of Grapevine berry inner necrosis virus. , 2003, Molecular Plant-Microbe Interactions.

[48]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[49]  J. Keski‐Oja,et al.  Secretion of human latent TGF-β-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-β , 2002 .

[50]  Zuzana Dobbie,et al.  Processing of gene expression data generated by quantitative real-time RT-PCR. , 2002, BioTechniques.

[51]  D. Rifkin,et al.  Latent TGF‐β binding protein‐3 (LTBP‐3) requires binding to TGF‐β for secretion , 2002 .

[52]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[53]  A. Görg,et al.  Improved silver staining protocols for high sensitivity protein identification using matrix‐assisted laser desorption/ionization‐time of flight analysis , 2001, Proteomics.

[54]  Juha Saharinen,et al.  Specific Sequence Motif of 8-Cys Repeats of TGF-β Binding Proteins, LTBPs, Creates a Hydrophobic Interaction Surface for Binding of Small Latent TGF-β , 2000 .

[55]  W. Yu,et al.  Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.

[56]  R. Beavis,et al.  Identification and Characterization of an Eight-cysteine Repeat of the Latent Transforming Growth Factor-β Binding Protein-1 that Mediates Bonding to the Latent Transforming Growth Factor-β1* , 1996, The Journal of Biological Chemistry.

[57]  K. Miyazono,et al.  Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[58]  D. Rifkin,et al.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.

[59]  K. Miyazono,et al.  Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue. , 1993, Cancer research.

[60]  K. Miyazono,et al.  Structure, Function and Possible Clinical Application of Transforming Growth Factor‐β , 1992 .

[61]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[62]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[63]  E. Deryugina.  Chorioallantoic Membrane Microtumor Model to Study the Mechanisms of Tumor Angiogenesis, Vascular Permeability, and Tumor Cell Intravasation. , 2016, Methods in molecular biology.

[64]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[65]  Helen Diller Family.  Targeting the TGFβ signalling pathway in disease , 2012 .

[66]  I. Tweel.  Sample size determination , 2010 .

[67]  J. Quigley,et al.  Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules. , 2008, Methods in enzymology.

[68]  D. Rifkin,et al.  Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  B. Park,et al.  Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. , 2005, Current opinion in oncology.

[70]  D. Rifkin,et al.  Methods for measuring TGF-b using antibodies, cells, and mice. , 2005, Methods in molecular medicine.

[71]  J. Keski‐Oja,et al.  Secretion of human latent TGF-beta-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-beta. , 2002, Journal of cell science.

[72]  D. Rifkin,et al.  Latent TGF-beta binding protein-3 (LTBP-3) requires binding to TGF-beta for secretion. , 2002, FEBS letters.

[73]  C. Trautwein,et al.  Evidence for the decreased expression of the latent TGF-beta binding protein and its splice form in human liver tumours. , 2001, Scandinavian journal of gastroenterology.

[74]  J. Keski‐Oja,et al.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. , 2000, Molecular biology of the cell.

[75]  R. Beavis,et al.  Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-beta binding protein-1 that mediates bonding to the latent transforming growth factor-beta1. , 1996, The Journal of biological chemistry.

[76]  K. Miyazono,et al.  Structure, function and possible clinical application of transforming growth factor-beta. , 1992, The Journal of dermatology.